Deepika Jalota - 10 Feb 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
SVP, Regulatory Affairs and QA
Signature
/s/ Winston Kung, by power of attorney
Issuer symbol
PMVP
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 15:28:06 UTC
Previous filing
18 Aug 2021
Next filing
13 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Award $0 +68,100 $0.000000 68,100 10 Feb 2022 Common Stock 68,100 $16.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.